| ESX secretion systems: mycobacterial evolution to counter host immunity MI Gröschel, F Sayes, R Simeone, L Majlessi, R Brosch Nature Reviews Microbiology 14 (11), 677-691, 2016 | 391 | 2016 |
| Cytosolic Access of Mycobacterium tuberculosis: Critical Impact of Phagosomal Acidification Control and Demonstration of Occurrence In Vivo R Simeone, F Sayes, O Song, MI Gröschel, P Brodin, R Brosch, L Majlessi PLoS pathogens 11 (2), e1004650, 2015 | 239 | 2015 |
| Recombinant BCG expressing ESX-1 of Mycobacterium marinum combines low virulence with cytosolic immune signaling and improved TB protection MI Gröschel, F Sayes, SJ Shin, W Frigui, A Pawlik, M Orgeur, R Canetti, ... Cell reports 18 (11), 2752-2765, 2017 | 120 | 2017 |
| The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia MI Gröschel, CJ Meehan, I Barilar, M Diricks, A Gonzaga, M Steglich, ... Nature communications 11 (1), 2044, 2020 | 115* | 2020 |
| Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines SA Prabowo, MI Gröschel, EDL Schmidt, A Skrahina, T Mihaescu, ... Medical microbiology and immunology 202, 95-104, 2013 | 94 | 2013 |
| Therapeutic vaccines for tuberculosis—a systematic review MI Gröschel, SA Prabowo, PJ Cardona, JL Stanford, TS Van der Werf Vaccine 32 (26), 3162-3168, 2014 | 87 | 2014 |
| Non-steroidal anti-inflammatory drugs as host-directed therapy for tuberculosis: a systematic review VM Kroesen, MI Gröschel, N Martinson, A Zumla, M Maeurer, ... Frontiers in immunology 8, 772, 2017 | 86 | 2017 |
| Pathogen-based precision medicine for drug-resistant tuberculosis MI Gröschel, TM Walker, TS van der Werf, C Lange, S Niemann, M Merker PLoS pathogens 14 (10), e1007297, 2018 | 66 | 2018 |
| CD4+ T Cells Recognizing PE/PPE Antigens Directly or via Cross Reactivity Are Protective against Pulmonary Mycobacterium tuberculosis Infection F Sayes, A Pawlik, W Frigui, MI Gröschel, S Crommelynck, C Fayolle, ... PLoS pathogens 12 (7), e1005770, 2016 | 66 | 2016 |
| Type VII secretion systems in Gram-positive bacteria D Bottai, MI Gröschel, R Brosch Protein and sugar export and assembly in Gram-positive bacteria, 235-265, 2017 | 62 | 2017 |
| Perspectives for personalized therapy for patients with multidrug‐resistant tuberculosis C Lange, WA Alghamdi, MH Al‐Shaer, S Brighenti, AH Diacon, ... Journal of internal medicine 284 (2), 163-188, 2018 | 52 | 2018 |
| A convolutional neural network highlights mutations relevant to antimicrobial resistance in Mycobacterium tuberculosis AG Green, CH Yoon, ML Chen, Y Ektefaie, M Fina, L Freschi, MI Gröschel, ... Nature communications 13 (1), 3817, 2022 | 50 | 2022 |
| GenTB: A user-friendly genome-based predictor for tuberculosis resistance powered by machine learning MI Gröschel, M Owens, L Freschi, R Vargas, MG Marin, J Phelan, Z Iqbal, ... Genome medicine 13, 1-14, 2021 | 45 | 2021 |
| Multiplexed quantitation of intraphagocyte Mycobacterium tuberculosis secreted protein effectors F Sayes, C Blanc, LS Ates, N Deboosere, M Orgeur, F Le Chevalier, ... Cell Reports 23 (4), 1072-1084, 2018 | 42 | 2018 |
| Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement J Domínguez, MJ Boeree, E Cambau, D Chesov, F Conradie, V Cox, ... The Lancet Infectious Diseases 23 (4), e122-e137, 2023 | 37 | 2023 |
| Prioritising children and adolescents in the tuberculosis response of the WHO European Region MI Gröschel, M van den Boom, GB Migliori, M Dara European Respiratory Review 28 (151), 2019 | 33 | 2019 |
| Global impact of COVID-19 on childhood tuberculosis: an analysis of notification data L Ranasinghe, J Achar, MI Gröschel, E Whittaker, PJ Dodd, JA Seddon The Lancet Global Health 10 (12), e1774-e1781, 2022 | 27 | 2022 |
| A diagnostic algorithm to investigate pyrazinamide and ethambutol resistance in rifampin-resistant Mycobacterium tuberculosis isolates in a low-incidence setting S Andres, MI Gröschel, D Hillemann, M Merker, S Niemann, K Kranzer Antimicrobial Agents and Chemotherapy 63 (2), 10.1128/aac. 01798-18, 2019 | 25 | 2019 |
| Immunology in tuberculosis: challenges in monitoring of disease activity and identifying correlates of protection R van Altena, S Duggirala, M IP Groschel, T S. van der Werf Current pharmaceutical design 17 (27), 2853-2862, 2011 | 23 | 2011 |
| Phenotypic and transcriptomic analyses of seven clinical Stenotrophomonas maltophilia isolates identify a small set of shared and commonly regulated genes involved in the … I Alio, M Gudzuhn, P Pérez García, D Danso, MC Schoelmerich, U Mamat, ... Applied and environmental microbiology 86 (24), e02038-20, 2020 | 19 | 2020 |